Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 254
Last updated 2022-08-19
Summary
The purpose of this study is to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress with a particular pattern.
Conditions
Sponsors & Collaborators
-
ALS Association
collaborator OTHER - collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Matthew Harms, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-08
- Primary Completion
- 2021-07-27
- Completion
- 2022-06-29
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
NCT06083584 ·Status: RECRUITING
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390 ·Status: COMPLETED
-
Phenotype, Genotype and Biomarkers 2
NCT04875416 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
NCT00213824 ·Status: TERMINATED
-
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235 ·Status: RECRUITING
-
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
NCT02559869 ·Status: COMPLETED
-
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS
NCT02686268 ·Status: COMPLETED
-
Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
NCT07007390 ·Status: NOT_YET_RECRUITING
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT02460679 ·Status: COMPLETED ·Phase: PHASE2
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
Study of Predictive Factors of Progression of Motor Neurone Disease
NCT02360891 ·Status: COMPLETED
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420 ·Status: RECRUITING
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments
NCT04816227 ·Status: RECRUITING
-
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
NCT04394871 ·Status: RECRUITING
-
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 ·Status: UNKNOWN
-
ASSESS ALL ALS Study
NCT06578195 ·Status: RECRUITING
-
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
NCT06318598 ·Status: RECRUITING
-
Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
NCT02969759 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis
NCT04953494 ·Status: UNKNOWN
-
Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids
NCT07260981 ·Status: COMPLETED
-
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
NCT05137665 ·Status: RECRUITING